Mirador Capital Partners LP Celldex Therapeutics, Inc. Transaction History

Mirador Capital Partners LP

  • $529 Million
  • Q4 2024

A detailed history of Mirador Capital Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 119,492 shares of CLDX stock, worth $2.66 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
119,492
Previous 116,147 2.88%
Holding current value
$2.66 Million
Previous $3.95 Million 23.47%
% of portfolio
0.57%
Previous 0.72%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025
BUY
$23.31 - $32.4 $77,971 - $108,378
3,345 Added 2.88%
119,492 $3.02 Million
Q3 2024

Oct 04, 2024
BUY
$32.06 - $44.56 $120,802 - $167,902
3,768 Added 3.35%
116,147 $3.95 Million
Q2 2024

Jul 12, 2024
BUY
$32.76 - $42.56 $249,631 - $324,307
7,620 Added 7.27%
112,379 $4.16 Million
Q1 2024

Apr 17, 2024
SELL
$35.22 - $51.88 $110,978 - $163,473
-3,151 Reduced 2.92%
104,759 $4.4 Million
Q4 2023

Jan 19, 2024
BUY
$22.61 - $40.65 $2,080 - $3,739
92 Added 0.09%
107,910 $4.28 Million
Q3 2023

Oct 05, 2023
BUY
$25.45 - $37.46 $78,971 - $116,238
3,103 Added 2.96%
107,818 $2.97 Million
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $115,889 - $146,459
3,826 Added 3.79%
104,715 $3.55 Million
Q1 2023

Apr 14, 2023
SELL
$34.78 - $47.43 $162,387 - $221,450
-4,669 Reduced 4.42%
100,889 $3.63 Million
Q4 2022

Feb 09, 2023
SELL
$27.78 - $45.38 $43,614 - $71,246
-1,570 Reduced 1.47%
105,558 $4.7 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $17,252 - $28,553
760 Added 0.71%
107,128 $3.01 Million
Q2 2022

Aug 05, 2022
BUY
$20.5 - $37.33 $334,560 - $609,225
16,320 Added 18.12%
106,368 $2.87 Million
Q1 2022

May 06, 2022
BUY
$27.64 - $39.32 $110,449 - $157,122
3,996 Added 4.64%
90,048 $3.07 Million
Q4 2021

Feb 02, 2022
BUY
$35.68 - $56.27 $440,148 - $694,146
12,336 Added 16.73%
86,052 $3.33 Million
Q3 2021

Nov 09, 2021
SELL
$28.95 - $55.99 $143,678 - $277,878
-4,963 Reduced 6.31%
73,716 $3.98 Million
Q2 2021

Jul 27, 2021
BUY
$20.71 - $35.37 $62,192 - $106,216
3,003 Added 3.97%
78,679 $2.63 Million
Q1 2021

Apr 29, 2021
BUY
$16.19 - $29.91 $792,128 - $1.46 Million
48,927 Added 182.91%
75,676 $1.56 Million
Q4 2020

Jan 20, 2021
BUY
$14.99 - $22.75 $19,232 - $29,188
1,283 Added 5.04%
26,749 $469,000
Q3 2020

Nov 12, 2020
BUY
$9.65 - $15.19 $61,103 - $96,183
6,332 Added 33.09%
25,466 $378,000
Q2 2020

Aug 06, 2020
BUY
$1.61 - $13.41 $12,561 - $104,624
7,802 Added 68.85%
19,134 $249,000
Q1 2020

May 11, 2020
BUY
$1.55 - $3.07 $17,564 - $34,789
11,332 New
11,332 $27,000

Others Institutions Holding CLDX

# of Institutions
194
Shares Held
64.9M
Call Options Held
1.65M
Put Options Held
973K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.04B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Mirador Capital Partners LP Portfolio

Follow Mirador Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email